MedAlliance Announces First Patient Enrolled in the 3,300 Pati... - 01 September 2021 08:00

GENEVA, Sept. 1, 2021, /PRNewswire-AsiaNet/ -- MedAlliance is pleased to announce the enrollment of the first patient in the ground-breaking coronary randomized controlled study "SELUTION DeNovo". This study utilizes SELUTION SLR(TM), a novel sirolimus drug-eluting balloon [DEB], versus a limu...

  Alithea Genomics Launches BRB-Seq Kits for High-Throughput RNA... - 31 August 2021 21:00

LAUSANNE, Switzerland, Aug. 31, 2021 /PRNewswire-AsiaNet/-- Alithea Genomics, a rapidly growing player in the transcriptomics field, has announced today the launch of its first MERCURIUS BRB-seq kits, which enable high-throughput and cost-efficient RNA-seq library preparation from a wide range of RNA sampl...

  CellCarta expands its biomarker capabilities for clinical tria... - 31 August 2021 21:00

MONTREAL, Aug. 31, 2021 /PRNewswire-AsiaNet/ -- CellCarta and Olink Proteomics AB announced today a strategic collaboration to offer Olink(R) Target 96 & Target 48 to pharmaceutical and biotech customers, advancing targeted protein biomarker quantification in clinical studies. Logo - https:/...

  Organ transplants fell by a third worldwide during first wave ... - 31 August 2021 09:01

MILAN, Aug. 31, 2021 /PRNewswire-AsiaNet/ -- The number of solid organ transplants performed during the first wave of COVID-19 in 2020 plunged by 31% compared to the previous year, according to a new global study presented at the European Society for Organ Transplantation (ESOT) Congress 202...

  Thrombosis Research Institute (TRI) Shares Six New GARFIELD-AF... - 31 August 2021 07:42

LONDON, Aug. 30, 2021 /PRNewswire-AsiaNet/ -- - Four GARFIELD-AF e-posters shine light on managing atrial fibrillation (AF) in patients with clinically challenging conditions and diabetes, as well as on AF trial populations - Two RIVER e-posters provide two-year outcomes data and ins...

  Manipal Hospitals launches the first Radixact System with Sync... - 27 August 2021 23:19

BENGALURU, India, Aug. 27 /PRNewswire-AsiaNet/ -- Manipal Hospitals, India's second largest multi-speciality hospital chain, has launched the first-of-its-kind advanced Radixact System with the Synchrony Automatic, Real-time Motion Synchronization Technology, for the precise treatment of canc...

  RedHill Biopharma Reports Second Quarter 2021 Financial Result... - 26 August 2021 22:55

TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire-AsiaNet/-- - Achieved record quarterly revenues of $21.5 million for Q2/2021, 4.5% increase from Q1/2021 despite challenging market conditions; Cash balance1 of approximately $71.5 million as of June 30, 2021 - Record Talicia(R) quarterly prescripti...

  INOVIO Receives Authorization to Conduct Phase 3 Efficacy Tria... - 26 August 2021 22:00

PLYMOUTH MEETING, Pa., Aug. 26, 2021 /PRNewswire-AsiaNet/ -- -- INOVIO's global Phase 3 efficacy trial receives authorization to proceed from Brazil; other countries to follow -- INOVIO to conduct INNOVATE Phase 3 efficacy trial with partner Advaccine in areas of world in need of COVID-...

  Genomics England Announces Appointment Of New Chief Scientific... - 26 August 2021 21:00

LONDON, Aug. 26, 2021 /PRNewswire-AsiaNet/ -- Genomics England today announces the appointment of Professor Matt Brown as the organisation's new Chief Scientific Officer following a rigorous recruitment process. Photo - https://mma.prnewswire.com/media/1602034/Professor_Matt_Brown.jpg ...

  RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of... - 26 August 2021 20:25

TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire-AsiaNet/ Opaganib demonstrated strong inhibition of COVID-19 Delta variant in a human bronchial epithelial cells model, adding to prior data demonstrating potent inhibition of all COVID-19 variants tested to date Opaganib's unique, host-targeted, dua...